Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
55/100
Pipeline Velocity
22/100
Trial Completion Rate
93/100
Pipeline Concentration
100/100
Pipeline Freshness
53/100
Activity
Last 14 days
OSU6162 as add-on in SSRI/SNRI-resistant Depression (ODEN): a Double-blind, Placebo-controlled Evaluation of Efficacy and Safety
OSU6162 in Bipolar Depression: An Open-label, Flexible Dose Study (OBID)
Evaluation of the Digital Delivery of Person-centered Transitional Care to Empower Adolescents With Chronic Childhood-onset Diseases: The Digi-STEPSTONES Study
Comparison of Different Objective Nociceptive Measurement Methods During General Anesthesia or Sedation Under Surgery
Reconstructive Surgical Therapy of Peri-implantitis-related Osseous Defects. A Multicenter Randomized Controlled Clinical Trial
The Effectiveness and Cost-effectiveness of Early Intervention to Correct the Position of a Palatally Displaced Maxillary Permanent Canine: A Multicentre RCT
Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF): a Randomized Controlled Trial
A Person-centred Approach to Pictorial Support in Care for Children (PicPecc)
Air-polishing in the Treatment of Peri-implantitis - a Randomized Controlled Trial
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)